Scheme 1.
Experimental design. Schematic illustration of the co-introduction of CAP and Cb-Vp as the exogenous irradiation-free photosynthetic bacteria-based platform for photodynamic cancer therapy with the continuous output of O2 (tumor hypoxia alleviation) and 1O2 (tumor therapy), achieving the enhanced photodynamic therapeutic effects and outcome.